Industry News
Melissa Turner

Melissa Turner is director of health care and life sciences content at SmartBrief. She edits science, medical and health care delivery newsletters and oversees development of content marketing pieces for SmartBrief’s health care clients.

Read All Stories from Melissa Turner

A new urgency for addressing social determinants of health
A new urgency for addressing social determinants of health

COVID-19 cast social gaps and inequities into sharper relief.

Reimagining health and wellness post-pandemic
Reimagining health and wellness post-pandemic

The pandemic could transform the way we manage health.

Industry transformation: A silver lining of COVID-19
Industry transformation: A silver lining of COVID-19

Practices that had moved further into value-based care were more resilient when crisis hit.

Editor’s take – Health care and life sciences:  R&D mobilizes, the ultimate disruptor and heroism on the front lines
Editor’s take – Health care and life sciences:  R&D mobilizes, the ultimate disruptor and heroism on the front lines

No story is more important or compelling right now than the one being written on the front lines.

FasterCures: 100-plus vaccines and treatments fill the growing COVID-19 pipeline
FasterCures: 100-plus vaccines and treatments fill the growing COVID-19 pipeline

R&D for a novel coronavirus vaccine and cure is moving rapidly, but the work will take time and money.

Editor’s take – Health care and life sciences: Google might have your health data, the ACA (again) and tax relief
Editor’s take – Health care and life sciences: Google might have your health data, the ACA (again) and tax relief

A suprising Google partnership, the ACA's murky future and a few long-sought gifts for health care stakeholders captured attention in Q4.

Editor’s take – health care and life sciences. Vaping-linked illness, affordability and Medicare for All
Editor’s take – health care and life sciences. Vaping-linked illness, affordability and Medicare for All

A worrisome spate of illnesses tied to vaping, continued emphasis on health care costs (and drug prices in particular), and Medicare for All were top of mind in Q3.

Editor’s take – Health care and life sciences: Price transparency, measles and continued disruption
Editor’s take – Health care and life sciences: Price transparency, measles and continued disruption

Health care costs, antivax sentiment and Amazon remain in the spotlight.

What’s trending? From home care to artificial intelligence, don’t miss these most-read stories.

Senior fitness class
Senior fitness class

Social determinants of health have a major influence over health outcomes, yet historically the health care system hasn't had the ability to address them. Here's how that's changing.